NFATC2 and cancer: Super-enhancers have been found in genes involved in T-cell activation (IL2RA/CD25, CD30, and FYN) and known cancer genes (TP73, CCR4, TIAM2, NFATC1, NFATC2, and PIK3R1) in ATL cells [72].